Increasing the accuracy of testing for anti-cancer therapeutics with Tecan's D300e Digital Dispenser

In this video, zPREDICTA CEO and founder Julia Kirshner, discusses the benefits of using Tecan's D300e Digital Dispenser for combination treatments in cell cultures to develop laboratory models for more accurate testing of anti-cancer therapeutics.

This interview was filmed at SLAS2020 - watch other highlights from the show here >>

Join this webinar with Dr. Kirshner on automating tumor-specific 3D cultures for anti-cancer drug screening >>